Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21252725

Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Thorac Oncol
Publication date
2011 Feb
First author
Guo S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Thorac Oncol. 2010 Jun;5(6):867-73. doi: 10.1097/jto.0b013e3181d95c87.
    note
    Source null
    related pmid
    20521354
    relationship
    Comment on

Authors and identifiers

  1. name
    Guo S
    type
    Author
  2. name
    Liang Y
    type
    Author
  3. name
    Zhou Q
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Guo S
    type
    Author
  2. name
    Liang Y
    type
    Author
  3. name
    Zhou Q
    type
    Author
bibliography ids
  1. nci-bib-052dad169233a617109dd389
book metadata
content sha256
b8f46301d4292f729a8d24f0822c48bd7f4ffebec926f307a199d73eee238a21
document type
citation
dois
  1. 10.1097/JTO.0b013e3182061d8c
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:21252725
immutable id
pubmed:21252725@b8f46301d4292f729a8d24f0822c48bd7f4ffebec926f307a199d73eee238a21
journal
abbreviation
J Thorac Oncol
issn electronic
1556-1380
issn print
1556-0864
issue
2
name
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
nlm unique id
101274235
pages
406-8; author reply 408
volume
6
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Thorac Oncol. 2010 Jun;5(6):867-73. doi: 10.1097/jto.0b013e3181d95c87.
    note
    Source null
    related pmid
    20521354
    relationship
    Comment on
outcomes validated
false
pmid
21252725
provenance
batch id
edef4b7f1a2a505cd5a9
provider
NCBI PubMed ESummary
record sha256
dd3e3e5b6a4f8c9a4718eaccf4506ea4f7c6b61f4a2a58c0b3d68a06721c061c
response sha256
d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
retrieved at
2026-09-09T23:46:38.027615+00:00
publication date
display
2011 Feb
precision
month
year
2011
publication types
  1. Journal Article
  2. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21252725/
title
Complement and correction for meta-analysis of patients with extensive-stage small cell lung cancer managed with irinotecan/cisplatin versus etoposide/cisplatin as first-line chemotherapy.

Preserved source evidence · Not medical advice